Pulmonx Corporation LUNG
3.12 USD +0.14 (+4.53%)
Nov 12, 2026, 12:13 PM EST
2.88 Day range 3.17
1.13 52-week range 3.25
- YTD
- +40.95%
- 1 year
- +58.93%
LUNG revenue history
Revenue is income from the company’s ordinary business activities.
90,497,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 90,497,000 | 6,708,000 | 8.01% |
| FY 2024 | 2024-12-31 | 83,789,000 | 15,114,000 | 22.01% |
| FY 2023 | 2023-12-31 | 68,675,000 | 15,013,000 | 27.98% |
| FY 2022 | 2022-12-31 | 53,662,000 | 5,246,000 | 10.84% |
| FY 2021 | 2021-12-31 | 48,416,000 | 15,683,000 | 47.91% |
| FY 2020 | 2020-12-31 | 32,733,000 | 138,000 | 0.42% |
| FY 2019 | 2019-12-31 | 32,595,000 | 12,591,000 | 62.94% |
| FY 2018 | 2018-12-31 | 20,004,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:02:21.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.